Brick & Kyle Associates’s Immunogen Inc IMGN Stock Holding History

Brick & Kyle Associates’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-300	Closed	-$2K	–	474
2014 Q4	$2K	Buy	+300	New	+$2.74K	﹤0.01%	417

Other funds holding IMGN

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Brick & Kyle Associates's IMGN Position: Q1 2015 in Review

Brick & Kyle Associates sold out of Immunogen Inc (IMGN) in Q1 2015, closing a stake of 300 shares — an estimated $2K sold.

Brick & Kyle Associates first reported a position in IMGN in Q4 2014 and held it in 1 quarter. The position peaked at $2K in Q4 2014. 141 funds tracked by Wall St. Rank hold IMGN as of Q1 2015.

Brick & Kyle Associates reported no remaining Immunogen Inc position as of Q1 2015 after selling out during the quarter.
Brick & Kyle Associates sold 300 Immunogen Inc shares in Q1 2015, an estimated $2K.
Brick & Kyle Associates first reported a position in Immunogen Inc in Q4 2014 and held it in 1 quarter.
Brick & Kyle Associates's Immunogen Inc position peaked at $2K in Q4 2014.
141 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2015.

Based on Brick & Kyle Associates's 13F filing for Q1 2015, filed 9 Apr 2015.